Sign Up to Receive Your Personalised Learning Resources

JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Highlights from ESMO GI 2024
New study shows combined power of deep learning and radiologists in prostate cancer detection
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
Sponsored content
Emerging Cell Therapy Approaches in Relapsed/Refractory Acute Myeloid Leukaemia in Older Adults
Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape
CE/CME ACCREDITED
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Greatest hits of 2024
RAS mutations and personalized cancer care: Targeting the future
CE/CME ACCREDITED
Quad Pro Quo: Deciphering the role of anti-CD38 quadruplets in newly diagnosed multiple myeloma (NDMM)
Sponsored content
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results
Highlights from ESMO GI 2024
New study shows combined power of deep learning and radiologists in prostate cancer detection
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
Sponsored content
Emerging Cell Therapy Approaches in Relapsed/Refractory Acute Myeloid Leukaemia in Older Adults
Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape
CE/CME ACCREDITED
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Greatest hits of 2024
RAS mutations and personalized cancer care: Targeting the future
CE/CME ACCREDITED
Quad Pro Quo: Deciphering the role of anti-CD38 quadruplets in newly diagnosed multiple myeloma (NDMM)
Sponsored content
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results
Highlights from ESMO GI 2024
New study shows combined power of deep learning and radiologists in prostate cancer detection
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
Sponsored content
Emerging Cell Therapy Approaches in Relapsed/Refractory Acute Myeloid Leukaemia in Older Adults
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Niraparib as first-line maintenance treatment in ovarian cancer
View
Cross-border collaboration is key to reducing inequalities in childhood cancer care
View
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
View
Trastuzumab deruxtecan shows clinical benefit in patients with HER2-ultralow metastatic breast cancer
View
The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy
View
Looking to the future in the treatment of steroid-refractory chronic GvHD
View
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
View
Dr Andrada ÈšurcaÈ™ on precision, empathy and paediatric radiotherapy: touchONCOLOGY Future Leader 2025
View
Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)
View
Mesothelioma and Immunotherapies
View
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGY
Sign me up!